Single-nucleus RNA sequencing reveals cell type-specific transcriptome alterations of Down syndrome hippocampus using the Dp16 mouse model

Springer Science and Business Media LLC - Tập 45 - Trang 1305-1315 - 2023
Zuolin Zhou1, Chunchun Zhi1, Die Chen1, Zhaowei Cai2, Xiaoling Jiang1
1The Children’s Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China
2Laboratory Animal Research Center, Zhejiang Chinese Medical University, Hangzhou, China

Tóm tắt

Down syndrome (DS), the most frequently occurring human chromosomal disorder, is caused by trisomy 21. The exact molecular effects of trisomy on certain cell populations in the brain remain poorly understood. The purpose of this study was to investigate the effects of trisomy on the transcriptomes of various types of neurons and nonneuronal cells in the hippocampus. A total of 8993 nuclei from the WT and 6445 nuclei from the Dp16 hippocampus were analyzed by single-nucleus RNA sequencing (snRNA-seq). Cell clustering was achieved by the Seurat program. Hippocampal cells were grouped into multiple neuronal and nonneuronal populations. Only a limited number of trisomic genes were upregulated (q < 0.001) over 1.25-fold in a specific type of hippocampal cell. Specifically, deregulation of genes associated with synaptic signaling and organization was observed in multiple cell populations, including excitatory neurons, oligodendrocytes, and microglia. This observation suggests the potential importance of synapse deficits in DS. Interestingly, GO annotation of the upregulated genes suggested potential activation of the immune system by hippocampal excitatory neurons. Fewer trisomic genes were altered in nonneuronal cells than in neurons. Notably, microglial transcriptome analysis revealed significantly (q < 0.001) increased expression of C1qb and C1qc, which suggested potential involvement of complement-mediated synapse loss mediated by microglia in DS. The trisomy-related hippocampal deficits should be driven by a small amount, not all, of the trisomic genes in a specific type of cell. Our work may help to narrow down both the molecular and cellular targets for future gene therapies in DS.

Tài liệu tham khảo

Ábrahám H, Vincze A, Veszprémi B, Kravják A, Gömöri É, Kovács GG, Seress L (2012) Impaired myelination of the human hippocampal formation in Down syndrome. Int J Dev Neurosci 30:147–158 Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH (2020) Down syndrome. Nat Rev Dis Prim 9:1–20 Araujo BHS, Kaid C, De Souza JS, Gomes Da Silva S, Goulart E, Caires LCJ, Musso CM, Torres LB, Ferrasa A, Herai R, Zatz M, Okamoto OK, Cavalheiro EA (2018) Down syndrome iPSC-Derived astrocytes impair neuronal synaptogenesis and the mTOR pathway in vitro. Mol Neurobiol 55:5962–5975 Aziz NM, Guedj F, Pennings JLA, Olmos-Serrano JL, Siegel A, Haydar TF, Bianchi DW (2018) Dis Models Mech 11:dmm031013 Bally PB, Murai KK (2021) Astrocytes in Down syndrome across the lifespan. Front Cell Neurosci 15:702685 Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC (2009) The “Down Syndrome Critical Region” is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 29:5938–5948 Cai Z, Xiao Z, Wang Y, Liu H, Zhang K, Zhen X, Jiang X (2020) Comparative analysis of the down syndrome hippocampal non-coding RNA transcriptomes using a mouse model. Genes Genom 42:1259–1265 Chen C, Jiang P, Xue H, Peterson SE, Tran HT, McCann AE, Parast MM, Li S, Pleasure DE, Laurent LC, Loring JF, Liu Y, Deng W (2014) Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat Commun 5:4430 Dierssen M (2012) Down syndrome: the brain in trisomic mode. Nat Rev Neurosci 13:844–858 Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y (2011) Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome. Mamm Genome 22:674–684 Garcia O, Torres M, Helguera P, Coskun P, Busciglio J (2010) A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down’s syndrome. PLoS ONE 5:e14200 Guedes JR, Ferreira PA, Costa JM, Cardoso AL, Peça J (2022) Microglia‐dependent remodeling of neuronal circuits. J Neurochem (Online ahead of print) Guidi S, Bonasoni P, Ceccarelli C, Santini D, Gualtieri F, Ciani E, Bartesaghi R (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol 18:180–197 Haas MA, Bell D, Slender A, Lana-Elola E, Watson-Scales S, Fisher EM, Tybulewicz VL, Guillemot F (2013) Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome. PLoS ONE 8:e78561 Hao Y, Hao S, Andersen-Nissen E et al (2021) Integrated analysis of multimodal single-cell data. Cell 184:3573–3587 Ishihara K, Akiba S (2017) A Comprehensive diverse ‘-omics’ approach to better understanding the molecular pathomechanisms of Down syndrome. Brain Sci 7:44 Jin M, Xu R, Wang L et al (2022) Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer’s disease. Cell Stem Cell 29:1135–1153 Klein JA, Haydar TF (2022) Neurodevelopment in Down syndrome: concordance in humans and models. Front Cell Neurosci 16:941855 Koenig KA, Oh S, Stasko MR, Roth EC, Taylor HG, Ruedrich S, Wang ZI, Leverenz JB, Costa ACS (2021) High resolution structural and functional MRI of the hippocampus in young adults with Down syndrome. Brain Commun 3:fcab088 Li Q, Barres BA (2018) Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol 18:225–242 Li Z, Yu T, Morishima M, Pao A, LaDuca J, Conroy J, Nowak N, Matsui S, Shiraishi I, Yu YE (2007) Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16:1359–1366 Mizuno GO, Wang Y, Shi G, Wang Y, Sun J, Papadopoulos S, Broussard GJ, Unger EK, Deng W, Weick J, Bhattacharyya A, Chen C, Yu G, Looger LL, Tian L (2018) Aberrant calcium signaling in astrocytes inhibits neuronal excitability in a human Down syndrome stem cell model. Cell Rep 24:355–365 Moyer AJ, Gardiner K, Reeves RH (2021) All creatures great and small: new approaches for understanding Down syndrome genetics. Trends Genet 37:444–459 Olmos-Serrano JL, Kang HJ, Tyler WA et al (2016) Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron 89:1208–1222 Palmer CR, Liu CS, Romanow WJ, Lee M, Chun J (2021) Altered cell and RNA isoform diversity in aging Down syndrome brains. Proc Natl Acad Sci 118:e2114326118 Pinto B, Morelli G, Rastogi M, Savardi A, Fumagalli A, Petretto A, Bartolucci M, Varea E, Catelani T, Contestabile A, Perlini LE, Cancedda L (2020) Rescuing over-activated microglia restores cognitive performance in juvenile animals of the Dp(16) mouse model of Down syndrome. Neuron 108:887–904 Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:177–184 Reiche L, Küry P, Göttle P (2019) Aberrant oligodendrogenesis in down syndrome: shift in gliogenesis? Cells Basel 8:1591 Reinholdt LG, Ding Y, Gilbert GT, Czechanski A, Solzak JP, Roper RJ, Johnson MT, Donahue LR, Lutz C, Davisson MT (2011) Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn. Mamm Genome 22:685–691 Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23:1018–1027 Wang C, Yue H, Hu Z, Shen Y, Ma J, Li J, Wang X, Wang L, Sun B, Shi P, Wang L, Gu Y (2020) Microglia mediate forgetting via complement-dependent synaptic elimination. Science 367:688–694 Yu T, Liu C, Belichenko P et al (2010) Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res 1366:162–171 Zeisel A, Munoz-Manchado AB, Codeluppi S, Lonnerberg P, La Manno G, Jureus A, Marques S, Munguba H, He L, Betsholtz C, Rolny C, Castelo-Branco G, Hjerling-Leffler J, Linnarsson S (2015) Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347:1138–1142 Zhong S, Ding W, Sun L, Lu Y, Dong H, Fan X, Liu Z, Chen R, Zhang S, Ma Q, Tang F, Wu Q, Wang X (2020a) Decoding the development of the human hippocampus. Nature 577:531–536 Zhong S, Wang M, Zhan Y, Zhang J, Yang X, Fu S, Bi D, Gao F, Shen Y, Chen Z (2020b) Single-nucleus RNA sequencing reveals transcriptional changes of hippocampal neurons in APP23 mouse model of Alzheimer’s disease. Biosci Biotechnol Biochem 84:919–926 Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523